Press Releases

Investor Resources
Contact Us
Investor ResourcesPress Releases

Press Releases

Cardiol Therapeutics Reports 2018 AGM Results


June 13, 2019

Cardiol Therapeutics to Webcast Annual General Meeting on June 12


June 10, 2019

Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD


June 3, 2019

Cardiol Therapeutics Commences Trading on the OTCQX


May 30, 2019

Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A


March 28, 2019

Cardiol Therapeutics to Present at the 2019 LD Micro Virtual Conference


March 12, 2019

Cardiol Therapeutics Appoints Thomas Moffatt as Chief Commercial Officer


March 6, 2019

Cardiol Therapeutics Inc. Closes Over-Allotment


January 18, 2019

Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT”


December 20, 2018

2025 Cardiol Therapeutics. All right reserved.